This Incubator Wants to Help Startups Cope with Tough Regulations
If you’re building a new social network, creating a tech-enabled food delivery business, or developing an artificial-intelligence translation tool, there aren’t many demanding rules to adhere to. But if your startup deals with issues such as health care, finance, or education, things can be rather more difficult.
“Because [these industries are] so essential to human needs, government is involved,” explained Rachel Haot, managing director of the startup incubator 1776, speaking at EmTech MIT 2016 on Wednesday. By necessity, that leads to regulation. “Government has to protect the rights and safety of people,” Haot said.

Problem is, startups are often naive about this: they may have a good idea, but they can be unaware of onerous rules that sometimes make implementation difficult. Haot says 1776 can help by offering guidance to startups navigating heavily regulated areas.
She points to procurement—the formal process through which large organizations and governments purchase products and services—as a good example of an area where her organization can help. Meant to prevent corruption and reduce risk, the rules around procurement are intended to give the buyer assurance that a given company won’t go out of business before delivering the promised product or service.
“These requirements can be so onerous that startups that could provide a better, cheaper service may not be able to enter the procurement process,” Haot said.
To overcome such problems, 1776 has eschewed the traditional incubator model, Haot said, and instead views itself as sort of a “college campus.” It offers entrepreneurs and innovators from large institutions the chance to network with government officials and learn about the regulations that are most relevant to them.
That way, the company hopes, red tape may no longer seem quite so burdensome.
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.